Correlation Between Indaptus Therapeutics and Neurobo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Indaptus Therapeutics and Neurobo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Indaptus Therapeutics and Neurobo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Indaptus Therapeutics and Neurobo Pharmaceuticals, you can compare the effects of market volatilities on Indaptus Therapeutics and Neurobo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Indaptus Therapeutics with a short position of Neurobo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Indaptus Therapeutics and Neurobo Pharmaceuticals.
Diversification Opportunities for Indaptus Therapeutics and Neurobo Pharmaceuticals
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Indaptus and Neurobo is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Indaptus Therapeutics and Neurobo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurobo Pharmaceuticals and Indaptus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Indaptus Therapeutics are associated (or correlated) with Neurobo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurobo Pharmaceuticals has no effect on the direction of Indaptus Therapeutics i.e., Indaptus Therapeutics and Neurobo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Indaptus Therapeutics and Neurobo Pharmaceuticals
Given the investment horizon of 90 days Indaptus Therapeutics is expected to generate 1.28 times more return on investment than Neurobo Pharmaceuticals. However, Indaptus Therapeutics is 1.28 times more volatile than Neurobo Pharmaceuticals. It trades about -0.03 of its potential returns per unit of risk. Neurobo Pharmaceuticals is currently generating about -0.08 per unit of risk. If you would invest 122.00 in Indaptus Therapeutics on October 24, 2024 and sell it today you would lose (36.00) from holding Indaptus Therapeutics or give up 29.51% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 88.89% |
| Values | Daily Returns |
Indaptus Therapeutics vs. Neurobo Pharmaceuticals
Performance |
| Timeline |
| Indaptus Therapeutics |
| Neurobo Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Indaptus Therapeutics and Neurobo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Indaptus Therapeutics and Neurobo Pharmaceuticals
The main advantage of trading using opposite Indaptus Therapeutics and Neurobo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Indaptus Therapeutics position performs unexpectedly, Neurobo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurobo Pharmaceuticals will offset losses from the drop in Neurobo Pharmaceuticals' long position.| Indaptus Therapeutics vs. Rezolute | Indaptus Therapeutics vs. Tempest Therapeutics | Indaptus Therapeutics vs. Forte Biosciences | Indaptus Therapeutics vs. ABVC Biopharma |
| Neurobo Pharmaceuticals vs. Allarity Therapeutics | Neurobo Pharmaceuticals vs. Virax Biolabs Group | Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |